AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  AIDS (London)

• Publication date

  2010-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e32833a3967PMID 20502317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV

  2010cited by this paper
• Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

  2009cited by this paper
• Use of risk equations for predicting disease progression in HIV infection.

  2009cited by this paper
• Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

  2009cited by this paper
• More on HIV-associated Kaposi's sarcoma.

  2008cited by this paper
• Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals

  2008cited by this paper
• Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)

  2008cited by this paper
• Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005

  2008cited by this paper
• Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters

  2008cited by this paper
• More on HIV-Associated Kaposi's Sarcoma

  2008cited by this paper
• Trends in perimortal conditions and mortality rates among HIV-infected patients

  2007cited by this paper
• Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.

  2007cited by this paper
• HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.

  2007cited by this paper
• Trends and determinants of severe morbidity in HIV‐infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004 *

  2007cited by this paper
• Trends in Opportunistic Infections in the Pre–and Post–Highly Active Antiretroviral Therapy Eras Among HIV-Infected Children in the Perinatal AIDS Collaborative Transmission Study, 1986–2004

  2007cited by this paper
• Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.

  2007cited by this paper
• Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.

  2006influential reference
• Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

  2006cited by this paper
• Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

  2006cited by this paper
• Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

  2006cited by this paper
• Hospitalizations for Metabolic Conditions, Opportunistic Infections, and Injection Drug Use Among HIV Patients: Trends Between 1996 and 2000 in 12 States

  2005cited by this paper
• Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France

  2005cited by this paper
• In the era of highly active antiretroviral therapy, why are HIV‐infected patients still admitted to hospital for an inaugural opportunistic infection?

  2005cited by this paper
• Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

  2004cited by this paper
• Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.

  2004cited by this paper
• The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003

  2004cited by this paper
• Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis

  2001cited by this paper
• Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents

  2001cited by this paper
• Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

  2000cited by this paper
• AIDS across Europe, 1994-98: the EuroSIDA study.

  2000cited by this paper
• Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

  1999influential reference
• AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

  1999cited by this paper
• AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.

  1999cited by this paper
• Natural history of HIV infection in the era of combination antiretroviral therapy.

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection

  1998cited by this paper
• The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

  1998cited by this paper
• Diagnosis?

  1987cited by this paper

• Unmasking Mycobacterium avium: two case reports of cutaneous lesions in HIV patients after initiation of an integrase inhibitor-based regimen

  2026cites this paper
• Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis—A Narrative Review

  2025cites this paper
• Incidence of AIDS-defining Illness by Cancer Status in an Observational Study among Medicaid Beneficiaries Living with HIV in the United States, 2001 - 2015.

  2025cites this paper
• Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium

  2025cites this paper
• Significant Mortality Reduction from Severe Pneumocystis jirovecii Pneumonia in People Living with HIV and Treated in the Intensive Care Unit, Croatia, 2002–2023

  2025influential citation
• Estimated burden of serious mycoses in Poland

  2025cites this paper
• Prevalence, Microbiological Characteristics, and Outcome of Disseminated Nontuberculous Mycobacterial Infection in People Living With HIV

  2025cites this paper
• Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022.

  2025cites this paper
• Toxoplasma gondii and the Brain: Frenemies? Or Just Outright Foes?

  2025cites this paper
• Pneumocystis jirovecii Pneumonia and HIV-Associated Nephropathy in Acute HIV Infection

  2024cites this paper
• Potential Advantages of a Well-balanced Nutrition Regimen for People Living with Human Immunodeficiency Virus Type -1

  2024cites this paper
• The incidence and prevalence of serious fungal diseases in Tunisia.

  2024cites this paper
• Global prevalence, mortality, and main characteristics of HIV-associated pneumocystosis: A systematic review and meta-analysis

  2024cites this paper
• Critical Insights: Severe Outcomes of Pneumocystis Pneumonia: A 10‐year Retrospective Cohort Study

  2024cites this paper
• Southern African HIV Clinicians Society guideline on the management of non-tuberculous mycobacteria in people with HIV

  2024cites this paper
• Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis

  2024cites this paper
• Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients

  2024cites this paper
• Hospital Readmissions among Persons with HIV in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies.

  2023cites this paper
• Prevalence and Characteristics of Non-tuberculous Mycobacteria (NTM) Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-analysis

  2023influential citation
• Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection

  2023cites this paper
• Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era.

  2023cites this paper
• Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives

  2023cites this paper
• No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV

  2023cites this paper
• Non-HIV Kaposi Sarcoma in an Immunocompetent Patient with High-Risk Behavior: Elucidating Subtypes and Risk Factors for Diagnosis

  2023cites this paper
• Pneumocystis pneumonia in COVID-19 patients: A comprehensive review

  2023cites this paper
• A contemporary investigation of burden and natural history of aspergillosis in people living with HIV/AIDS

  2023cites this paper
• Fungal infections in Sudan: An underestimated health problem

  2023cites this paper
• Burden of fungal infections in Kenya

  2023cites this paper
• A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone

  2023cites this paper
• Survey on Hepatitis B virus and Hepatitis C Virus Coinfection in the Human Immunodeficiency Virus-infected Patients

  2022cites this paper
• Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

  2022cites this paper
• Hidradenitis Suppurativa in Patients with HIV: A Scoping Review

  2022cites this paper
• Disseminated Mycobacterium avium Complex Disease

  2022cites this paper
• Evolving epidemiology of pneumocystis pneumonia: Findings from a longitudinal population-based study and a retrospective multi-center study in Germany

  2022cites this paper
• Clinical characteristics of patients with acquired immunodeficiency syndrome having respiratory symptoms as the initial manifestations: A retrospective study

  2022cites this paper
• Burden of serious fungal infections in Honduras

  2022cites this paper
• Neglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity

  2022cites this paper
• Clinical characteristics of nontuberculous mycobacterial disease in people living with HIV/AIDS in South Korea: A multi-center, retrospective study

  2022cites this paper
• Peripheral immune phenotypes and T cell receptor repertoire in pneumocystis pneumonia in HIV-1 infected patients.

  2022cites this paper
• Extrapulmonary pneumocystosis in an antiretroviral therapy-naïve, HIV-positive patient.

  2022cites this paper
• Long-Term Effects of Radiation on Lymphocytes and Risk of Opportunistic Infections

  2022cites this paper
• Clinical Impact of Noninvasive Plasma Microbial Cell-Free Deoxyribonucleic Acid Sequencing for the Diagnosis and Management of Pneumocystis jirovecii Pneumonia: A Single-Center Retrospective Study

  2022cites this paper
• Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial

  2022cites this paper
• Recent Trends in the Epidemiology of Fungal Infections.

  2021cites this paper
• Prevalence of bacterial pneumonia among HIV-Seropositive patients in East Africa: Review

  2021cites this paper
• Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria - a cross sectional study

  2021cites this paper
• Estimated burden of serious fungal infections in Togo

  2021cites this paper
• Different Trends of Distinct Time Points of AIDS Events Following HIV Diagnosis in Various At-risk Populations: A Retrospective Nationwide Cohort Study in Taiwan

  2021cites this paper
• Granulomatous Pneumocystis jiroveci Pneumonia in an HIV-Positive Patient on Antiretroviral Therapy: A Diagnostic Challenge

  2021cites this paper
• Initial diagnosis of HIV/AIDS in patients presenting to the emergency department: Imaging and clinical findings at a single institution.

  2021cites this paper
• Preserved Mucosal-Associated Invariant T-Cell Numbers and Function in Idiopathic CD4 Lymphocytopenia

  2021cites this paper
• Determining the burden of fungal infections in Zimbabwe

  2021cites this paper
• Disseminated coccidioidomycosis in a patient who is immunocompromised in the setting of immune reconstitution inflammatory syndrome

  2021cites this paper
• Idiopathic CD4 Lymphopenia

  2021cites this paper
• The burden of serious fungal infections in Azerbaijan

  2021cites this paper
• Serious fungal disease incidence and prevalence in Indonesia

  2021cites this paper
• Ring-enhancing Brain Lesions in a Patient with Advanced Human Immunodeficiency Virus from the Central United States of America

  2020cites this paper
• Admission C-Reactive Protein-to-Albumin Ratio Predicts the 180-Day Mortality of AIDS-Related Pneumocystis Pneumonia

  2020cites this paper
• Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and with HIV

  2020cites this paper
• Dosing Recommendations for Prevention and Treatment of Cryptosporidiosis

  2020cites this paper
• Possible Diagnostic Delays and Missed Prevention Opportunities in Pneumocystis Pneumonia Patients Without HIV: Analysis of Commercial Insurance Claims Data-United States, 2011-2015.

  2020cites this paper
• for the Prevention and Treatment of Opportunistic Infections in Adults and

  2020cites this paper
• Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV.

  2020cites this paper
• Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?

  2020cites this paper
• Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis

  2020cites this paper
• Recent epidemiology of Pneumocystis pneumonia in Japan.

  2020cites this paper
• Estimated Burden of Fungal Infections in Oman

  2020influential citation
• Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia

  2020cites this paper
• Impact of Strain Competition on Bacterial Resistance in Immunocompromised Populations

  2020cites this paper
• Current burden of serious fungal infections in Republic of Congo

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• The outcome predictors and therapeutic strategy of pneumocystis pneumonia in North China: a double-center retrospective study

  2020influential citation
• Pneumocystis pneumonia after use of corticosteroids in a man with severe alcoholic hepatitis

  2020cites this paper
• Disseminated atypical mycobacteriosis in HIV-infected patient with predominant lesion of digestive system (clinical case)

  2020cites this paper
• General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus

  2020cites this paper
• Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study

  2020cites this paper
• intestinal parasitic infections in adult living with hiv in cochabamba bolivia

  2020cites this paper
• Mortality rate and prognostic factors for poor outcome in HIV-infected Bulgarian patients with Pneumocystis pneumonia over a 3-year period

  2020cites this paper
• Human Immunodeficiency Virus Infection

  2020cites this paper
• Opportunistic Infections

  2020cites this paper
• Mycobacteria and immunosuppression

  2020cites this paper
• Sleep and immune function among people living with human immunodeficiency virus (HIV)

  2020cites this paper
• The Burden of Serious Fungal Infections in Tajikistan

  2019cites this paper
• Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study

  2019cites this paper
• HIV/AIDS in small cities in Midwest Santa Catarina, south of Brazil: Clinical and epidemiological aspects, opportunistic infections.

  2019cites this paper
• The Burden of Serious Fungal Infections in Kyrgyzstan

  2019cites this paper
• Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality

  2019cites this paper
• Signs of Psychosis Leading to a Diagnosis of Progressive Multifocal Leukoencephalopathy: A Case Report

  2019cites this paper
• Estimated Burden of Serious Fungal Infections in Ghana

  2019cites this paper
• Invasive fungal disease in immunocompromised hosts with focus on diagnostics

  2019cites this paper
• A Model to Predict In-Hospital Mortality in HIV/AIDS Patients with Pneumocystis Pneumonia in China: The Clinical Practice in Real World

  2019cites this paper
• Opportunistic Infections

  2019cites this paper
• Opportunistic Infections

  2019cites this paper
• Coinfection of Cytomegalovirus and Cryptosporidiosis in a Patient With AIDS

  2019cites this paper
• HIV‐associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana

  2019cites this paper
• The outcome predictors and therapeutic strategy of pneumocystis pneumonia in North China: a double-center retrospective study

  2019influential citation
• HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management

  2019cites this paper
• AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

  2019cites this paper
• Changing Spectrum of Opportunistic Illnesses among HIV-Infected Taiwanese Patients in Response to a 10-Year National Anti-TB Programme

  2019cites this paper